Back

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Statin therapy: clinical role and current challenges Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Andrim Halili

Zealand university hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data
Doctor M. Abdelghani (Doha, QA)
Abstract Slides
Presentation thumbnail
Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study
Doctor V. Kyto (Turku, FI)
Abstract Slides
Presentation thumbnail
Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides
Presentation thumbnail
Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.
Doctor K. Stepien (Krakow, PL)
Abstract Slides
Presentation thumbnail
Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?
Doctor D. Cosmi (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Statin therapy: clinical role and current challenges

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources